BioSpace News Archive

Genetown

Akoya Biosciences to Showcase New Data on PhenoCycler-Fusion at the AACR Annual Meeting 2022

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that two important milestones on advancing the speed and scale of its spatial phenotyping solutions, will be presented during the American Association for Cancer Research 2022 Annual Meeting in New Orleans, April 8 to 13.

April 6, 2022
·
3 min read
New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor’s Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure

Daxor Corporation(Nasdaq: DXR), the global leader in blood volume measurement technology, today announces new data from Duke Heart that was presented on April 2nd at the American College of Cardiology (ACC) 71st Scientific Sessions and Expo in Washington, DC.

April 6, 2022
·
4 min read
Business

Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process

VolitionRx Limited, a multi-national epigenetics company, has announced the appointment of Sharon Ballesteros as U.S Head of Quality and Development Process.

April 6, 2022
·
6 min read
Biocytogen Subsidiary Eucure Biopharma Completes First Patient Dosing for Phase I Clinical Trial of YH003 (Anti-CD40 mAb) Triple Combination Therapy

Biocytogen subsidiary Eucure Biopharma announced the first patient dosing for a phase I clinical trial (No. YH003005) of YH003 (anti-CD40 monoclonal antibody, mAb) in combination with YH001 (anti-CTLA-4 mAb) and pembrolizumab (anti-PD-1 mAb) in Australia.

April 6, 2022
·
3 min read
Genetown

Bicycle Therapeutics to Participate in the 21st Annual Needham Virtual Healthcare Conference

Bicycle Therapeutics plc announced that management will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, 2022 at 8:45 a.m. ET.

April 6, 2022
·
1 min read
Business

Third Harmonic Bio Strengthens Management Team with Addition of Adrian S. Ray, Ph.D., as Chief Scientific Officer

Third Harmonic Bio announced today the appointment of Adrian S. Ray, Ph.D., as Chief Scientific Officer.

April 6, 2022
·
3 min read
Business

Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022

Biofrontera Inc. announced today preliminary, unaudited product revenues for the quarter ended March 31, 2022.

April 6, 2022
·
4 min read
Biotech Bay

Anixa Biosciences’ Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022

Anixa Biosciences, Inc. today announced that the inventor of its ovarian cancer CAR-T technology, Dr. José Conejo-Garcia, Chair of the Immunology Department at Moffitt Cancer Center, will be presenting at The 4th International Workshop on CAR-T (iwCAR-T) 2022 on Friday, April 29, 2022.

April 6, 2022
·
4 min read
Business

Alumis Expands Industry-Leading Leadership Team With Appointments of Sara Klein as General Counsel and Secretary and John R. Schroer as Chief Financial Officer

Alumis today announced the appointments of Sara Klein as general counsel and secretary and John R. Schroer as chief financial officer.

April 6, 2022
·
2 min read
BioCapital

Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative

Ceres Nanosciences, a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence.

April 6, 2022
·
2 min read